AMPIO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events.

On June 2, 2022, Ampio Pharmaceuticals, Inc. (the "Company") issued a press release containing a letter to stockholders from Michael A. Martino, Chief Executive Officer. A copy of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

        XX
   99.1      Press release, dated June 2, 2022.
    104    The cover page from this Current Report on Form 8-K, formatted in
           Inline XBRL.

© Edgar Online, source Glimpses